Dyadic International Inc.

DYAI

Healthcare Biotechnology

Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024.

Revenue
−61.4%
EPS
n/m
Free cash flow
n/m
Total debt
+0.80%

Quarter to September 2026, against a year earlier

0.33 0.02 −5.71%
Market cap
$14.0M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
2/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

Dyadic International Inc. (DYAI) EV/Sales

Alert me on EV/Sales

As of 13 November 2026, Dyadic International Inc. (DYAI) trades at a EV/Sales of 4.1×. Over the past ten years it has ranged from −18.5× (April 2016) to 197× (December 2015); the current reading is higher than 22% of that period. That is below the Biotechnology industry median of 8.6× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 8.8× (34.71%)
FY2024 13.5× 0.95%
FY2023 13.3× 47.34%
FY2022 9.0× (79.41%)
FY2021 43.9× (40.73%)
FY2020 74.1× 17.90%
FY2019 62.9× 633.31%
FY2018 8.6× 3,309.23%
FY2017 0.3× —
FY2016 −8.3× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 5.6× (36.05%)
Jun 2026 8.7× 17.11%
Mar 2026 7.4× (15.18%)
Dec 2025 8.8× (17.26%)
42 more quarters

Against its own ten years

Low −18.5× High 197×
Ten-year median 12.9×
Current reading's percentile 3

EV/Sales against peers

Company EV/Sales
NEUP Neuphoria Therapeutics Inc. compare −0.5×
ALGS Aligos Therapeutics, Inc. compare −0.3×
ALLR Allarity Therapeutics, Inc. compare n/m
NCEL NewcelX Ltd. compare n/m
LSTA Lisata Therapeutics, Inc. compare 0.3×
DYAI Dyadic International Inc. 4.1×
QNTM Quantum Biopharma Ltd. compare 4.2×
PLUR Pluri Inc. compare 23.1×
MCRB Seres Therapeutics, Inc. compare 46.7×
Biotechnology industry median 8.6×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on DYAI